3.95
                                            Schlusskurs vom Vortag:
              $3.87
            Offen:
              $3.91
            24-Stunden-Volumen:
                586.68K
            Relative Volume:
              0.65
            Marktkapitalisierung:
                $224.89M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-82.44M
            KGV:
              -2.1011
            EPS:
                -1.88
            Netto-Cashflow:
                $-66.75M
            1W Leistung:
              +0.00%
            1M Leistung:
              +1.54%
            6M Leistung:
                +121.91%
            1J Leistung:
              +36.68%
            Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Firmenname
                  
                      Black Diamond Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      617-417-5868
                    
                Adresse
                  
                      ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
                    
                Vergleichen Sie BDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                BDTX
                            
                             
                        Black Diamond Therapeutics Inc 
                           | 
                    3.95 | 220.34M | 0 | -82.44M | -66.75M | -1.88 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-16 | Fortgesetzt | Stifel | Buy | 
| 2025-09-04 | Eingeleitet | Guggenheim | Buy | 
| 2025-07-01 | Fortgesetzt | Raymond James | Outperform | 
| 2024-07-31 | Eingeleitet | Raymond James | Outperform | 
| 2023-07-14 | Eingeleitet | Piper Sandler | Overweight | 
| 2023-06-30 | Hochstufung | Stifel | Hold → Buy | 
| 2023-06-28 | Hochstufung | H.C. Wainwright | Neutral → Buy | 
| 2023-06-27 | Hochstufung | Wedbush | Neutral → Outperform | 
| 2022-03-29 | Herabstufung | Wedbush | Outperform → Neutral | 
| 2022-03-22 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2021-09-30 | Eingeleitet | Stifel | Hold | 
| 2021-01-07 | Eingeleitet | Wedbush | Outperform | 
| 2020-11-24 | Eingeleitet | Berenberg | Buy | 
| 2020-05-04 | Eingeleitet | H.C. Wainwright | Buy | 
| 2020-02-24 | Eingeleitet | Canaccord Genuity | Buy | 
| 2020-02-24 | Eingeleitet | Cowen | Outperform | 
| 2020-02-24 | Eingeleitet | JP Morgan | Overweight | 
| 2020-02-24 | Eingeleitet | Jefferies | Buy | 
                    Alle ansehen
                    
                  
                Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten
Volume spikes in Black Diamond Therapeutics Inc. stock – what they mean2025 AllTime Highs & Daily Profit Focused Screening - newser.com
Can Black Diamond Therapeutics Inc. stock hit record highs againLayoff News & Daily Volume Surge Trade Alerts - newser.com
Tools to assess Black Diamond Therapeutics Inc.’s risk profileJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
Is Black Diamond Therapeutics Inc. trending in predictive chart modelsMarket Movers & Safe Entry Trade Reports - newser.com
Can Black Diamond Therapeutics Inc. stock resist market sell offsTrade Signal Summary & Daily Technical Forecast Reports - newser.com
Using fundamentals and technicals on Black Diamond Therapeutics Inc.Portfolio Value Report & Reliable Price Breakout Alerts - newser.com
Can Black Diamond Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
Real time scanner hits for Black Diamond Therapeutics Inc. explainedQuarterly Investment Review & Weekly Hot Stock Watchlists - newser.com
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Is Black Diamond Therapeutics Inc. building a consolidation baseWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings? - sharewise.com
Volatility clustering patterns for Black Diamond Therapeutics Inc.Quarterly Portfolio Report & Daily Volume Surge Signals - newser.com
Chart based exit strategy for Black Diamond Therapeutics Inc.2025 Historical Comparison & Smart Investment Allocation Tips - newser.com
What analysts say about Black Diamond Therapeutics Inc stockGrowth vs. Value Investing & Free Get High Impact Recommendations - earlytimes.in
Black Diamond Therapeutics (BDTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Published on: 2025-10-27 19:48:31 - newser.com
Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):